2 completed. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Pericarditis, Tuberculous: new trials by email Literature Review of Pericarditis, Tuberculous trials Research Report on Pericarditis, Tuberculous
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| High vs. Standard Dose Rifampicin for Effusive Tuberculous Pericarditis high dose Rifampicin (RIF) - Tuberculous Pericarditis, HIV Status | Phase 2 | Completed | University of Cape Town | 52 | 2022-01-10 | 2026-09-01 |
| A Trial of Adjunctive Prednisolone and Mycobacterium w Immunotherapy in Tuberculous Pericarditis Prednisolone, Mycobacterium w immunotherapy - Tuberculous Pericarditis | Phase 3 | Completed | University of Cape Town | 1400 | 2008-12-01 | 2014-09-03 |
Actinomycetales Infections (2) · Bacterial Infections (2) · Bacterial Infections and Mycoses (2) · Cardiovascular Diseases (2) · Cardiovascular Infections (2) · Gram-Positive Bacterial Infections (2) · Heart Diseases (2) · Infections (2) · Mycobacterium Infections (2) · Pericarditis (2) · Tuberculosis (2) · Tuberculosis, Cardiovascular (2) · Tuberculosis, Extrapulmonary (2)
Immuvac (1) · Methylprednisolone (1) · Prednisolone (1) · Rifampin (1)
South Africa (2)
Mpiko U Ntsekhe, Professor (1) · Salim Yusuf, M.D. (1)